EUVIMEDScopri EUVIMED
Open access · CC BY 4.0

Engineered injectable scaffolds as synthetic niches for minimally invasive monitoring of metastatic breast cancer progression

Kathryn Kang, Grace K. Darlak, Jian Toy, Hanna Kim, James Messina, Chih‐Horng Wu, Ethan Wachman, Jyotirmoy Roy, Zhen Xu, Jacqueline S. Jeruss, Lonnie D. Shea

Bioengineering & Translational Medicine · 2026-11-20

DOI: 10.1002/btm2.70201 ↗

At a glance

Journal article in Bioengineering & Translational Medicine, published online on 2026-11-20. Written by Kathryn Kang and 10 co-authors. 50 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Institutes of Health.

AbstractDati bibliograficiCiteRelated studies

Abstract (original language)

Current methods for detecting metastasis rely on patient self‐reporting of symptoms and late‐stage imaging, thereby limiting early detection and opportunities for intervention at low disease burden. Herein, we developed an injectable biomaterial scaffold that functions as a synthetic metastatic niche, enabling the assessment of immune responses in distant tissues reflective of disease progression. The scaffolds were fabricated using a top‐down approach to create an open‐top cubic structure and were delivered into the subcutaneous space with fibrin. These scaffolds recruited immune cells that were subsequently isolated for downstream analysis. Gene expression profiling of the isolated cells was used to generate a score that reflects disease progression. Finally, we demonstrated the feasibility of fine‐needle aspiration as a minimally invasive biopsy approach to collect cells from the scaffolds, which recapitulated scores indicative of disease progression. These injectable scaffolds, functioning as a synthetic metastatic niche, enable longitudinal assessment of metastatic disease.

Funding

  • National Institutes of Health

Cite

APA

Kang, K., Darlak, G. K., Toy, J., Kim, H., Messina, J., Wu, C., Wachman, E., Roy, J., Xu, Z., Jeruss, J. S., & Shea, L. D. (2026). Engineered injectable scaffolds as synthetic niches for minimally invasive monitoring of metastatic breast cancer progression. Bioengineering & Translational Medicine. https://doi.org/10.1002/btm2.70201

Vancouver

Kang K, Darlak GK, Toy J, Kim H, Messina J, Wu C, et al. Engineered injectable scaffolds as synthetic niches for minimally invasive monitoring of metastatic breast cancer progression. Bioengineering & Translational Medicine. 2026. doi:10.1002/btm2.70201

BibTeX
@article{Kang2026,
  author = {Kang, Kathryn and Darlak, Grace K. and Toy, Jian and Kim, Hanna and Messina, James and Wu, Chih‐Horng and Wachman, Ethan and Roy, Jyotirmoy and Xu, Zhen and Jeruss, Jacqueline S. and Shea, Lonnie D.},
  title = {Engineered injectable scaffolds as synthetic niches for minimally invasive monitoring of metastatic breast cancer progression},
  journal = {Bioengineering & Translational Medicine},
  year = {2026},
  doi = {10.1002/btm2.70201}
}
Start for free →